US Patent Issued to Juno Therapeutics on April 8 for "Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)" (Washington Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,741, issued on April 8, was assigned to Juno Therapeutics Inc. (Seattle).

"Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)" was invented by Andreia Costa (Seattle), Rupesh Amin (Seattle), Jenna Bailey (Seattle), Samriti Bedi (Newcastle, Wash.), Brian Belmont (Seattle), Aye Chen (Seattle), Stephen Jacob Goldfless (Seattle), Eric Jeffery (Seattle), Yue Jiang (Seattle), Yeonjoo Oh (Seattle), Madeline Williams (Seattle), Collin Hauskins (Seattle) and Catherine Sierra (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are receptor tyrosine kinase-like orphan receptor 1 (ROR1)-bin...